Outcomes of Patients With Long-Term Treatment Response to Vascular Endothelial Growth Factor-Targeted Therapy for Metastatic Renal Cell Cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F17%3A73583799" target="_blank" >RIV/61989592:15110/17:73583799 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/17:10366225 RIV/00216208:11130/17:10366225 RIV/00216208:11140/17:10366225 RIV/00179906:_____/17:10366225 and 6 more
Result on the web
<a href="http://dx.doi.org/10.1016/j.clgc.2017.06.006" target="_blank" >http://dx.doi.org/10.1016/j.clgc.2017.06.006</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.clgc.2017.06.006" target="_blank" >10.1016/j.clgc.2017.06.006</a>
Alternative languages
Result language
angličtina
Original language name
Outcomes of Patients With Long-Term Treatment Response to Vascular Endothelial Growth Factor-Targeted Therapy for Metastatic Renal Cell Cancer
Original language description
Although targeted therapies are the mainstay of treatment for metastatic renal cell carcinoma there are limited data on the outcomes of patients with long-term responses. We report the outcomes of a registry-based study of patients continuously treated with first-line targeted therapy for at least 24 months. There were clinically important differences in survival between patients who achieved complete response and those with partial response or stable disease. These differences had not been described before and are important for treatment optimization of this patient subgroup.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
<a href="/en/project/NV15-34678A" target="_blank" >NV15-34678A: Prognostic and predictive molecular factors in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Clinical Genitourinary Cancer
ISSN
1558-7673
e-ISSN
—
Volume of the periodical
15
Issue of the periodical within the volume
6
Country of publishing house
US - UNITED STATES
Number of pages
7
Pages from-to
"E1047"-"E1053"
UT code for WoS article
000417112200017
EID of the result in the Scopus database
—